Ove the years RHC has been a star ASX performer but its struggled more recently and post COVID it’s still over 13% below its March 2020 levels while other Healthcare Sector stocks have soared. We wouldn’t be chasing RHC around $70 but another dip towards $60 and the risk / reward will look attractive.
MM is neutral to bullish RHC
Add To Hit List